Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nuclear receptor subfamily 2 group F member 6 (NR2F6)
- Target
- NR2F6
- Molecular classification
- Nuclear receptor, Transcription factor
01
Overview
NR2F6 is an orphan nuclear receptor that functions as a transcriptional regulator, primarily acting as a repressor. It plays a role in modulating immune responses, maintaining epithelial barrier function, and regulating metabolic homeostasis. In cancer, NR2F6 expression is often upregulated and associated with immunosuppression and poor clinical outcomes. Due to its role as an intracellular immune checkpoint, NR2F6 is being investigated as a potential target for cancer immunotherapy. However, its complex context-dependent functions necessitate careful consideration of potential safety concerns.
- Other names
- V-erbA-related protein 2EAR-2EAR2
02
Mechanism of action
Transcriptional repression; modulation of immune checkpoint signaling.
03
Biological functions
Transcriptional regulationImmune response modulationRegulation of cell differentiationMetabolic homeostasis
04
Disease associations
CancerInflammatory bowel diseaseAutoimmune diseases
05
Safety considerations
Potential for broad immunosuppression if targeted systemicallyContext-dependent effects in cancer (tumor promotion vs. suppression)
06
Biomarkers
NR2F6 expression level in tumor microenvironmentNR2F6 expression in immune cells
Beyond the preview
Go deeper on Nuclear receptor subfamily 2 group F member 6 (NR2F6).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nuclear receptor subfamily 2 group F member 6 (NR2F6).